PHIO PHARMACEUTICALS CORP. Acquisitions, Net of Cash Acquired
PHIO PHARMACEUTICALS CORP. (PHIO) reported Acquisitions, Net of Cash Acquired of -$100.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q/A filed 2018-03-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2018-03-26
- PHIO PHARMACEUTICALS CORP. payments to acquire businesses, net of cash acquired for the quarter ending 2017-03-31 was -$100.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month |
|---|---|
| 2017-03-31 | -$100.00K 10-Q/A · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |